{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:30Z","timestamp":1791352290475,"version":"4.3.1"},"reference-count":81,"publisher":"American Psychiatric Association Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,5,1]]},"DOI":"10.1176\/appi.ajp.162.5.983","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T01:27:58Z","timestamp":1114824478000},"page":"983-991","source":"Crossref","is-referenced-by-count":101,"title":["Functional Brain Imaging Alterations in Acne Patients Treated With Isotretinoin"],"prefix":"10.1176","volume":"162","author":[{"given":"J. Douglas","family":"Bremner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Fani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Votaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn E.","family":"Brummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1625CHDEEBGG","doi-asserted-by":"crossref","unstructured":"Cunliffe WJ, van der Kerkhof PCM, Caputo R, Caicchini S, Cooper A, Fyrand OL, Gollnick H, Layton AM, Leyden JJ, Mascaro J-M, Ortonne J-P, Shalita A: Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194:351\u2013357","DOI":"10.1159\/000246134"},{"key":"R1625CHDJCEGG","doi-asserted-by":"crossref","unstructured":"Goulden V, Layton AM, Cunliffe WJ: Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 1995; 190:284\u2013287","DOI":"10.1159\/000246717"},{"key":"R1625CHDEGJCD","doi-asserted-by":"crossref","unstructured":"Jick SS, Kremers HM, Vasilakis-Scaramozza C: Isotretinoin use and risk of depression: psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000; 136:1231\u20131236","DOI":"10.1001\/archderm.136.10.1231"},{"key":"R1625CHDGAIFE","doi-asserted-by":"crossref","unstructured":"Wysowski DK, Pitts M, Beitz J: An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45:515\u2013519","DOI":"10.1067\/mjd.2001.117730"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Byrne A, Costello M, Greene E, Zibin T: Isotretinoin therapy and depression: evidence for an association. Irish J Psychosomatic Med 1998; 15:58\u201360","DOI":"10.1017\/S0790966700003530"},{"key":"R1625CHDJFAAG","unstructured":"Bremner JD: Does isotretinoin cause depression and suicide? Psychopharmacol Bull 2003; 37:5\u20139"},{"key":"R1625CHDIGHDI","doi-asserted-by":"crossref","unstructured":"Meyskens FLJ: Short clinical reports. J Am Acad Dermatol 1982; 6:732\u2013733","DOI":"10.1016\/S0190-9622(82)80054-6"},{"key":"R1625CHDHEEJD","unstructured":"Duke EE, Guenther L: Psychiatric reactions to the retinoids (letter). Canadian J Dermatology 1993; 5:467"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Bigby M, Stern RS: Adverse reactions to isotretinoin. J Am Acad Dermatol 1988; 18:543\u2013552","DOI":"10.1016\/S0190-9622(88)70078-X"},{"key":"R1625CHDHHGFF","doi-asserted-by":"crossref","unstructured":"Hazen PG, Carney JF, Walker AE, Stewart JJ: Depression: a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol 1983; 2:278\u2013279","DOI":"10.1016\/S0190-9622(83)80154-6"},{"key":"R1625CHDCGDFA","doi-asserted-by":"crossref","unstructured":"Middelkoop T: Roaccutane (isotretinoin) and the risk of suicide: case report and a review of the literature and pharmacovigilance reports. J Pharmacy Practice 1999; 12:374\u2013378","DOI":"10.1177\/089719009901200502"},{"key":"R1625CHDIICDB","unstructured":"Villalobos D, Ellis M, Snodgrass WR: Isotretinoin (Accutane)-associated psychosis (letter). Vet Hum Toxicol 1989; 31:362"},{"key":"atypb3","unstructured":"Bravard P, Krug M, Rzeznick JC: Isotretinoine et depression: soyons vigilants (letter). Nouvelle Dermatology 1993; 12:215"},{"key":"R1625CHDCAAHD","doi-asserted-by":"crossref","unstructured":"Scheinman PL, Peck GL, Rubinow DR, DiGiovanna JJ, Abangan DL, Ravin PD: Acute depression from isotretinoin. J Am Acad Dermatol 1990; 22:1112\u20131114","DOI":"10.1016\/S0190-9622(08)81018-3"},{"key":"R1625CHDDDBBE","doi-asserted-by":"crossref","unstructured":"Hull PR, Demkiw-Bartel C: Isotretinoin use in acne: prospective evaluation of adverse events. J Cutan Med Surg 2000; 4:66\u201370","DOI":"10.1177\/120347540000400205"},{"key":"R1625CHDIDIEF","doi-asserted-by":"crossref","unstructured":"Rodahl K, Moore T: Vitamin A content and toxicity of bear and seal liver. Biochem J 1943; 37:166\u2013168","DOI":"10.1042\/bj0370166"},{"key":"R1625CHDIEEAJ","doi-asserted-by":"crossref","unstructured":"Restak RM: Pseudotumor cerebri, psychosis, and hypervitaminosis A. J Nerv Ment Dis 1972; 155:155\u2013172","DOI":"10.1097\/00005053-197207000-00008"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"McCance-Katz EF, Price LH: Depression associated with Vitamin A intoxication (letter). Psychosomatics 1992; 33:117\u2013118","DOI":"10.1016\/S0033-3182(92)72033-7"},{"key":"R1625CHDGEADE","doi-asserted-by":"crossref","unstructured":"Fishbane S, Frei GL, Finger M, Dressler R, Silbiger S: Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis 1995; 25:346\u2013349","DOI":"10.1016\/0272-6386(95)90020-9"},{"key":"R1625CHDHAEGB","doi-asserted-by":"crossref","unstructured":"Lamberg L: Acne drug depression warnings highlight need for expert care. JAMA 1998; 279:1057","DOI":"10.1001\/jama.279.14.1057-JMN0408-2-1"},{"key":"R1625CHDEAIFJ","doi-asserted-by":"crossref","unstructured":"Cassileth BR, Lusk EJ, Tenaglia AN: A psychological comparison of patients with malignant melanoma and other dermatologic disorders. J Am Acad Dermatol 1982; 7:742\u2013746","DOI":"10.1016\/S0190-9622(82)70155-0"},{"key":"R1625CHDHDDJD","doi-asserted-by":"crossref","unstructured":"Shuster S, Fisher GH, Harris E, Binnel D: The effect of skin disease on self-image. Br J Dermatol 1978; 99:18\u201319","DOI":"10.1111\/j.1365-2133.1978.tb15214.x"},{"key":"R1625CHDHHDJF","unstructured":"Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM: The psychological impact of severe acne. Cutis 1985; 7:84\u201386"},{"key":"atypb5","unstructured":"Garrie SA, Garrie EV: Anxiety and skin diseases. Cutis 1978; 22:205\u2013208"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Medansky RS, Handler RM, Medansky DL: Self-evaluation of acne and emotion: a pilot study. Psychosomatics 1981; 22:379\u2013383","DOI":"10.1016\/S0033-3182(81)73507-2"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Rubinow DR, Peck GL, Squillace KM, Gantt GG: Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17:25\u201332","DOI":"10.1016\/S0190-9622(87)70166-2"},{"key":"R1625CHDGIFDC","doi-asserted-by":"crossref","unstructured":"Kellett SC, Gawkrodger DJ: The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140:273\u2013282","DOI":"10.1046\/j.1365-2133.1999.02662.x"},{"key":"R1625CHDHJBBF","doi-asserted-by":"crossref","unstructured":"Hyatt GA, Schmitt EA, Marsh-Armstrong N, McCaffery P, Drager UC, Dowling JE: Retinoic acid establishes ventral retinal characteristics. Development 1996; 122:195\u2013204","DOI":"10.1242\/dev.122.1.195"},{"key":"R1625CHDIDFBF","doi-asserted-by":"crossref","unstructured":"Wilson L, Gale E, Maden M: The role of retinoic acid in the morphogenesis of the neural tube. J Anat 2003; 203:357\u2013368","DOI":"10.1046\/j.1469-7580.2003.00230.x"},{"key":"R1625CHDGBDCB","doi-asserted-by":"crossref","unstructured":"Maden M, Holder N: Retinoic acid and development of the central nervous system. Bioessays 1992; 14:431\u2013438","DOI":"10.1002\/bies.950140702"},{"key":"R1625CHDCBCCE","doi-asserted-by":"crossref","unstructured":"Martinot JL, Hardy P, Feline A, Huret J-D, Mazoyer B, Attar-Levy D, Pappata S, Syrota A: Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147:1313\u20131317","DOI":"10.1176\/ajp.147.10.1313"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Smida RM: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243\u2013249","DOI":"10.1001\/archpsyc.1989.01810030049007"},{"key":"R1625CHDIFEJB","doi-asserted-by":"crossref","unstructured":"Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ: The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992; 22:607\u2013615","DOI":"10.1017\/S003329170003806X"},{"key":"R1625CHDFFJGJ","doi-asserted-by":"crossref","unstructured":"Ebert D, Feistel H, Barocka A: Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-99m-HMPAO SPECT. Psychiatry Res 1991; 40:247\u2013251","DOI":"10.1016\/0925-4927(91)90016-J"},{"key":"R1625CHDBJAEA","doi-asserted-by":"crossref","unstructured":"Buchsbaum MS, DeLisi LE, Holcomb H, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM: Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984; 41:1159\u20131166","DOI":"10.1001\/archpsyc.1984.01790230045007"},{"key":"R1625CHDGDHHE","doi-asserted-by":"crossref","unstructured":"Austin MP, Dougall N, Ross M, Murray C, O\u2019Carroll RE, Moffoot A, Ebmeier KP, Goodwin GM: Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic\/neurotic continuum. J Affect Disord 1992; 26:31\u201343","DOI":"10.1016\/0165-0327(92)90032-2"},{"key":"R1625CHDJEAHI","unstructured":"Mayberg HS, Lewis PJ, Regenold W, Wagner HN: Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35:929\u2013934"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Hurwitz TA, Clark C, Murphy E, Klonoff H, Martin WRW, Pate BD: Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry 1990; 35:684\u2013688","DOI":"10.1177\/070674379003500807"},{"key":"R1625CHDJJHJI","doi-asserted-by":"crossref","unstructured":"Biver F, Goldman S, Delvenne V, Luxen A, De Maertelaer V, Hubain P, Mendlewicz J, Lotstra F: Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994; 36:381\u2013388","DOI":"10.1016\/0006-3223(94)91213-0"},{"key":"R1625CHDGJFAD","doi-asserted-by":"crossref","unstructured":"Mayberg HS: Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994; 6:428\u2013442","DOI":"10.1176\/jnp.6.4.428"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8:1057\u20131061","DOI":"10.1097\/00001756-199703030-00048"},{"key":"R1625CHDHBGCH","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT: Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156:675\u2013682","DOI":"10.1176\/ajp.156.5.675"},{"key":"atypb11","doi-asserted-by":"crossref","unstructured":"Drevets WC, Price JL, Simpson JRJ, Todd RD, Reich T, Vannier M, Raichle ME: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824\u2013827","DOI":"10.1038\/386824a0"},{"key":"atypb12","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN, Robinson RG: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson\u2019s disease. Ann Neurol 1990; 28:57\u201364","DOI":"10.1002\/ana.410280111"},{"key":"atypb13","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE: Paralimbic frontal lobe hypometabolism in depression associated with Huntington\u2019s disease. Neurology 1992; 42:1791\u20131797","DOI":"10.1212\/WNL.42.9.1791"},{"key":"atypb14","doi-asserted-by":"crossref","unstructured":"Ring RA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RSJ, Dolan RJ: Depression in Parkinson\u2019s disease: a positron emission study. Br J Psychiatry 1994; 165:333\u2013339","DOI":"10.1192\/bjp.165.3.333"},{"key":"R1625CHDGICAH","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA: Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000; 48:830\u2013843","DOI":"10.1016\/S0006-3223(00)01036-2"},{"key":"R1625CHDBHIIC","doi-asserted-by":"crossref","unstructured":"Bremner JD, Vythilingam M, Vermetten E, Vaccarino V, Charney DS: Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression. Am J Psychiatry 2004; 161:637\u2013645","DOI":"10.1176\/appi.ajp.161.4.637"},{"key":"R1625CHDCFGAB","doi-asserted-by":"crossref","unstructured":"George MS, Ketter TA, Parekh PI, Rosinsky N, Ring HA, Pazzaglia PJ, Marangell LB, Callahan AM, Post RM: Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 1997; 9:55\u201363","DOI":"10.1176\/jnp.9.1.55"},{"key":"R1625CHDHFBBF","unstructured":"Drevets WC, Raichle ME: Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992; 28:261\u2013274"},{"key":"R1625CHDGCBEB","doi-asserted-by":"crossref","unstructured":"Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM: Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42:441\u2013447","DOI":"10.1001\/archpsyc.1985.01790280019002"},{"key":"R1625CHDFBIIH","doi-asserted-by":"crossref","unstructured":"Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS: Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiatry 1987; 22:545\u2013553","DOI":"10.1016\/0006-3223(87)90182-X"},{"key":"R1625CHDIEACC","doi-asserted-by":"crossref","unstructured":"Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58:631\u2013640","DOI":"10.1001\/archpsyc.58.7.631"},{"key":"R1625CHDCBHAI","doi-asserted-by":"crossref","unstructured":"Bremner JD, Innis RB, Salomon RM, Staib L, Ng CK, Miller HL, Bronen RA, Duncan J, Krystal JH, Rich D, Malison R, Price LH, Dey H, Soufer R, Charney DS: PET measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997; 54:364\u2013374","DOI":"10.1001\/archpsyc.1997.01830160092012"},{"key":"R1625CHDEEEBG","doi-asserted-by":"crossref","unstructured":"Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren D, Berman RM, Charney DS: Regional brain metabolic correlates of positron emission tomographic measurement of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA 2003; 289:3125\u20133134","DOI":"10.1001\/jama.289.23.3125"},{"key":"R1625CHDCBJDF","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56\u201362","DOI":"10.1136\/jnnp.23.1.56"},{"key":"R1625CHDIIHJF","doi-asserted-by":"crossref","unstructured":"Chren MM, Lasek RJ, Sahay AP, Sands LP: Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001; 5:105\u2013110","DOI":"10.1007\/BF02737863"},{"key":"R1625CHDCAACJ","doi-asserted-by":"crossref","unstructured":"Weinhard K, Eriksson L, Grootoonk S, Casey ME, Pietrzyk U, Heiss WD: Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16:804\u2013813","DOI":"10.1097\/00004728-199209000-00024"},{"key":"R1625CHDIHEHJ","doi-asserted-by":"crossref","unstructured":"Brownell GL, Kearfott KJ, Kairento A-L, Elmaleh DR, Alpert NM, Correia JA, Wechsler L, Ackerman RH: Quantitation of regional cerebral glucose metabolism. J Comput Assist Tomogr 1983; 7:919\u2013924","DOI":"10.1097\/00004728-198310000-00038"},{"key":"R1625CHDJEBDG","doi-asserted-by":"crossref","unstructured":"Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371\u2013388","DOI":"10.1002\/ana.410060502"},{"key":"R1625CHDDIGCD","doi-asserted-by":"crossref","unstructured":"Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M: The [14]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28:897\u2013916","DOI":"10.1111\/j.1471-4159.1977.tb10649.x"},{"key":"R1625CHDBHDBB","doi-asserted-by":"crossref","unstructured":"Robb RA, Hanson DP, Karwoski RA, Larson AG, Workman EL, Stacy MC: Analyze: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Comput Med Imaging Graph 1989; 13:433\u2013454","DOI":"10.1016\/0895-6111(89)90285-1"},{"key":"R1625CHDEDACC","unstructured":"Zubal IG, Zhang L, Tagare B, Duncan JS: 3-D registration of SPECT and MRI brain images (abstract). J Nucl Medicine 1993; 34:187"},{"key":"R1625CHDCFGEH","doi-asserted-by":"crossref","unstructured":"Bremner JD, Bronen RA, de Erasquin G, Vermetten E, Staib L, Ng CK, Soufer R, Charney DS, Innis RB: Development and reliability of a method for using magnetic resonance imaging for the definition of regions of interest for positron emission tomography. Clin Positron Imaging 1998; 1:145\u2013159","DOI":"10.1016\/S1095-0397(98)00015-6"},{"key":"R1625CHDBBFJE","doi-asserted-by":"crossref","unstructured":"Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, Staib LH, Charney DS: Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002; 51:273\u2013279","DOI":"10.1016\/S0006-3223(01)01336-1"},{"key":"R1625CHDDBAEH","doi-asserted-by":"crossref","unstructured":"Lai TJ, Payne ME, Byrum CE, Steffens D, Krishnan KR: Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 2000; 48:971\u2013975","DOI":"10.1016\/S0006-3223(00)01042-8"},{"key":"R1625CHDCAFIH","doi-asserted-by":"crossref","unstructured":"Goodman AB: Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 1998; 95:7240\u20137244","DOI":"10.1073\/pnas.95.13.7240"},{"key":"R1625CHDEEIEJ","doi-asserted-by":"crossref","unstructured":"Jentsch JD, Roth RH, Taylor JR: Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res 2000; 126:433\u2013453","DOI":"10.1016\/S0079-6123(00)26028-7"},{"key":"R1625CHDGAIIJ","unstructured":"Risch SC, Nemeroff CB: Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry 1992; 53:3\u20137"},{"key":"R1625CHDEJDFD","doi-asserted-by":"crossref","unstructured":"McCaffery P, Drager UC: High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci USA 1994; 91:7772\u20137776","DOI":"10.1073\/pnas.91.16.7772"},{"key":"R1625CHDBCGDJ","doi-asserted-by":"crossref","unstructured":"McCaffery P, Drager UC: Hot spots of retinoic acid synthesis in the developing spinal cord. Proc Natl Acad Sci USA 1994; 91:7194\u20137197","DOI":"10.1073\/pnas.91.15.7194"},{"key":"R1625CHDJGAGG","doi-asserted-by":"crossref","unstructured":"Farooqui SM: Induction of adenylate cyclase sensitive dopamine D2 receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sci 1994; 55:1887\u20131893","DOI":"10.1016\/0024-3205(94)00520-6"},{"key":"R1625CHDBEFEC","doi-asserted-by":"crossref","unstructured":"Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borreli E, Chambon P: Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 1998; 279:863\u2013867","DOI":"10.1126\/science.279.5352.863"},{"key":"R1625CHDCEJBE","doi-asserted-by":"crossref","unstructured":"Crandall J, Sakai Y, Zhang J, Koul O, Mineur Y, Crusio WE, McCaffery P: 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci USA 2004; 101:5111\u20135116","DOI":"10.1073\/pnas.0306336101"},{"key":"R1625CHDCBGJE","doi-asserted-by":"crossref","unstructured":"Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54:597\u2013606","DOI":"10.1001\/archpsyc.1997.01830190015002"},{"key":"atypb15","doi-asserted-by":"crossref","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Aranico O, Belzung C, Hen R: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301:805\u2013809","DOI":"10.1126\/science.1083328"},{"key":"atypb16","doi-asserted-by":"crossref","unstructured":"Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS: Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115\u2013117","DOI":"10.1176\/ajp.157.1.115"},{"key":"R1625CHDFEIAH","doi-asserted-by":"crossref","unstructured":"Sheline YI, Wang P, Gado M, Csernansky J, Vannier M: Hippocampal atrophy in major depression. Proc Natl Acad Sci USA 1996; 93:3908\u20133913","DOI":"10.1073\/pnas.93.9.3908"},{"key":"R1625CHDBBDBG","doi-asserted-by":"crossref","unstructured":"Johann V, Jeliaznik N, Schrage K, Mey J: Retinoic acid downregulates the expression of ciliary neurotrophic factor in rat Schwann cells. Neurosci Lett 2003; 339:13\u201316","DOI":"10.1016\/S0304-3940(02)01427-1"},{"key":"R1625CHDFEJGG","doi-asserted-by":"crossref","unstructured":"Goodman AB: Chromosomal locations and modes of action of genes in the retinoid (vitamin A) system support their involvement in the etiology of schizophrenia. Am J Med Genet Neuropsychiatr Genet 1995; 60:335\u2013348","DOI":"10.1002\/ajmg.1320600415"},{"key":"R1625CHDGDJIJ","doi-asserted-by":"crossref","unstructured":"Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51:62\u201370","DOI":"10.1001\/archpsyc.1994.03950010062008"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.5.983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T22:07:57Z","timestamp":1721858877000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.5.983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5,1]]}},"alternative-id":["10.1176\/appi.ajp.162.5.983"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.5.983","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}